As of April 16, 2025, Nuvectis Pharma (NVCT) has a market cap of $0.22 billion USD. According to our data, Nuvectis Pharma is ranked No.6868 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $0.22 B |
83.74%
|
Dec 31, 2024 | $0.12 B |
-35.13%
|
Dec 29, 2023 | $0.19 B |
11.20%
|
Dec 30, 2022 | $0.17 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Gilead Sciences
GILD
|
$131.74 B |
-0.002 M
|
![]() USA
|
![]() Amgen
AMGN
|
$158.77 B |
0.132 B
|
![]() USA
|
![]() Regeneron Pharmaceuticals
REGN
|
$60.99 B |
1.014 B
|
![]() USA
|
![]() Biogen
BIIB
|
$17.12 B |
0.000 M
|
![]() USA
|
![]() Moderna
MRNA
|
$10.14 B |
-0.001 M
|
![]() USA
|
![]() BioMarin Pharmaceutical
BMRN
|
$11.51 B |
-0.000 M
|
![]() USA
|
![]() Incyte
INCY
|
$11.31 B |
0.000 M
|
![]() USA
|
![]() Alnylam Pharmaceuticals
ALNY
|
$29.89 B |
-0.001 M
|
![]() USA
|
![]() Exelixis
EXEL
|
$10.23 B |
0.000 M
|
![]() USA
|
![]() Blueprint Medicines
BPMC
|
$5.21 B |
0.000 M
|
![]() USA
|
![]() Iovance Biotherapeutics
IOVA
|
$1.06 B |
-0.000 M
|
![]() USA
|
![]() Zymeworks
ZYME
|
$0.76 B |
-0.000 M
|
![]() Canada
|
![]() Relay Therapeutics
RLAY
|
$0.47 B |
-0.000 M
|
![]() USA
|
Market Cap | = | NVCT Stock Price | * | NVCT Shares Outstanding |
= | $9.53 | * | 23.39 M | |
= | $0.22 B |